David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
CALL
CarMax
KMX
$9.11B
| $847K | ﹤0.01% |
12,600
-4,200
| -25% | -$282K |
|
|
BPMC
3227
PUT
DELISTED
Blueprint Medicines
BPMC
| $846K | ﹤0.01% |
6,600
| – | – |
|
3228
AeroVironment
AVAV
$7.49B
| $845K | ﹤0.01% |
+2,967
| New | +$502K |
|
3229
GeneDx Holdings
WGS
$2.61B
| $845K | ﹤0.01% |
9,155
-390,549
| -98% | -$30.7M |
|
3230
Sprinklr
CXM
$1.75B
| $841K | ﹤0.01% |
99,355
+49,057
| +98% | +$393K |
|
3231
Entravision Communication
EVC
$752M
| $839K | ﹤0.01% |
361,619
-49,708
| -12% | -$100K |
|
3232
Virgin Galactic
SPCE
$450M
| $837K | ﹤0.01% |
306,671
+287,239
| +1,478% | +$879K |
|
3233
Rackspace Technology
RXT
$867M
| $836K | ﹤0.01% |
653,045
-360,979
| -36% | -$470K |
|
|
KC
3234
CALL
Kingsoft Cloud Holdings
KC
$3.15B
| $835K | ﹤0.01% |
+66,700
| New | +$863K |
|
3235
CALL
Deckers Outdoor
DECK
$12.1B
| $835K | ﹤0.01% |
8,100
| – | – |
|
3236
Midland States Bancorp
MSBI
$679M
| $834K | ﹤0.01% |
48,151
-4,657
| -9% | -$78.8K |
|
|
HTO
3237
H2O America
HTO
$2.67B
| $832K | ﹤0.01% |
+16,003
| New | +$851K |
|
3238
Gen Digital
GEN
$17.5B
| $832K | ﹤0.01% |
28,283
-111,338
| -80% | -$3.04M |
|
3239
Cardlytics
CDLX
$25.2M
| $831K | ﹤0.01% |
50,495
-35,666
| -41% | -$616K |
|
|
VZLA
3240
Vizsla Silver
VZLA
$1.42B
| $827K | ﹤0.01% |
+281,442
| New | +$733K |
|
3241
Fidelity MSCI Utilities Index ETF
FUTY
$2.28B
| $827K | ﹤0.01% |
15,728
-15,679
| -50% | -$806K |
|
3242
CALL
Prudential Financial
PRU
$41.5B
| $827K | ﹤0.01% |
7,700
-11,400
| -60% | -$1.18M |
|
3243
John B. Sanfilippo & Son
JBSS
$875M
| $827K | ﹤0.01% |
13,081
+131
| +1% | +$8.41K |
|
3244
CVR Energy
CVI
$3.81B
| $827K | ﹤0.01% |
30,809
-42,043
| -58% | -$925K |
|
3245
Occidental Petroleum Corp Warrants
OXY.WS
$34.4B
| $826K | ﹤0.01% |
39,904
| – | – |
|
|
NVMI
3246
PUT
Nova
NVMI
$11.7B
| $826K | ﹤0.01% |
3,000
| – | – |
|
3247
PUT
Allegiant Air
ALGT
$2.25B
| $824K | ﹤0.01% |
15,000
| – | – |
|
3248
PUT
Cimpress
CMPR
$2.14B
| $823K | ﹤0.01% |
17,500
+6,500
| +59% | +$284K |
|
3249
OceanFirst Financial
OCFC
$1.82B
| $821K | ﹤0.01% |
46,612
-27,919
| -37% | -$466K |
|
|
GOOD
3250
Gladstone Commercial Corp
GOOD
$635M
| $819K | ﹤0.01% |
57,179
-42,691
| -43% | -$606K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.